Caricamento...

Phase I trial of pelvic radiation, weekly cisplatin, and 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) for locally advanced cervical cancer

PURPOSE: This study assessed the safety/tolerability, pharmacokinetics, and clinical activity of three-times weekly intravenous 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in combination with once weekly intravenous cisplatin and daily pelvic radiation in patients with gyn...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Kunos, Charles A., Waggoner, Steven, von Gruenigen, Vivian, Eldermire, Elisa, Pink, John, Dowlati, Afshin, Kinsella, Timothy J.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2010
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2822897/
https://ncbi.nlm.nih.gov/pubmed/20145183
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-09-2469
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !